These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3116918

  • 1. Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.
    Van der Auwera P, Klastersky J.
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1061-8. PubMed ID: 3116918
    [Abstract] [Full Text] [Related]

  • 2. Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously.
    Van der Auwera P, Klastersky J.
    J Antimicrob Chemother; 1987 May; 19(5):623-35. PubMed ID: 2956228
    [Abstract] [Full Text] [Related]

  • 3. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Van der Auwera P, Klastersky J, Lieppe S, Husson M, Lauzon D, Lopez AP.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
    [Abstract] [Full Text] [Related]

  • 4. Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
    Van der Auwera P.
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1783-90. PubMed ID: 2556079
    [Abstract] [Full Text] [Related]

  • 5. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Shigeta S, Takahashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Matsumoto T, Kashitani F, Kaku M, Ooe H, Mochida C.
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.
    Lagast H, Husson M, Klastersky J.
    J Antimicrob Chemother; 1985 Sep; 16(3):341-7. PubMed ID: 2932416
    [Abstract] [Full Text] [Related]

  • 8. Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin.
    Van der Auwera P, Klastersky J.
    Antimicrob Agents Chemother; 1986 Dec; 30(6):892-5. PubMed ID: 3813515
    [Abstract] [Full Text] [Related]

  • 9. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.
    Lagast H, Klastersky J, Standiford H, Viollier A.
    Infection; 1984 Sep; 12(3):190-3. PubMed ID: 6432702
    [Abstract] [Full Text] [Related]

  • 14. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.
    Garraffo R, Drugeon HB, Dellamonica P, Bernard E, Lapalus P.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):614-21. PubMed ID: 2111658
    [Abstract] [Full Text] [Related]

  • 15. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.
    Parsley TL, Provonchee RB, Glicksman C, Zinner SH.
    Antimicrob Agents Chemother; 1977 Sep; 12(3):349-52. PubMed ID: 410362
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD, Pasiecznik K.
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [Abstract] [Full Text] [Related]

  • 17. Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Van Laethem Y, Lagast H, Klastersky J.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):435-9. PubMed ID: 6221694
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.
    Renneberg J, Walder M.
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1714-20. PubMed ID: 2511798
    [Abstract] [Full Text] [Related]

  • 20. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.
    Lagast H, Pascual-Lopez A, Dejace P, Klastersky J.
    Eur J Clin Microbiol; 1986 Feb; 5(1):98-102. PubMed ID: 3084248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.